Regional Business Director, Rare Diseases & Oncology jobs in United States
cer-icon
Apply on Employer Site
company-logo

Cogent Biosciences · 1 month ago

Regional Business Director, Rare Diseases & Oncology

positionUnited States
timeFull-time
remoteRemote
seniorityDirector/Executive
money$250K/yr - $300K/yr
date8+ years exp

Cogent Biosciences is a publicly traded biotechnology company dedicated to developing precision therapies for genetically defined diseases. The Regional Sales Director will lead and execute the commercial strategy for the rare disease and oncology portfolio, driving revenue growth and building high-performing sales teams while fostering relationships with healthcare providers and stakeholders.

BiotechnologyHealth CareMedicalTherapeutics
check
Growth Opportunities

Responsibilities

Develop and implement regional sales strategies aligned with corporate objectives
Achieve or exceed revenue targets for rare disease and oncology products
Recruit, coach, and mentor a team of Territory Managers and Account Executives
Foster a culture of accountability, collaboration, and continuous improvement
Identify and prioritize key accounts, centers of excellence, and KOLs
Drive market access initiatives and collaborate with Market Access and Medical Affairs teams
Build strong relationships with healthcare professionals, payers, and advocacy groups
Ensure compliance with all regulatory and ethical standards in promotional activities
Analyze regional performance metrics and market trends to inform strategy
Provide accurate forecasting and reporting to senior leadership

Qualification

Oncology experienceRare disease experienceSales leadershipStrategic planningPeople developmentCommunication skillsNegotiation skills

Required

Bachelor's degree in Life Sciences, Business, or related field
8+ years in pharmaceutical/biotech sales, with at least 3 years in oncology or rare disease
Proven track record of leading regional teams and achieving sales targets
Strong leadership and people development capabilities
Excellent communication, negotiation, and strategic planning skills
Deep understanding of oncology and rare disease market dynamics

Preferred

MBA

Benefits

Competitive pay
Performance-based bonus
Stock options
Insurance coverage (health, dental, life, and disability)
Competitive time-off
A 401(k) plan
Commuter/parking benefits

Company

Cogent Biosciences

twittertwittertwitter
company-logo
Cogent Biosciences is a biotechnology company that develops therapies for solid cancer tumors.
dateFounded in 2014
location
Waltham, Massachusetts, USA
people-size51-200 employees
web-link
https://www.cogentbio.com

Funding

Current Stage
Public Company
Total Funding
$1.6B
Key Investors
Commodore CapitalFairmount Funds ManagementSquare 1 Bank
2025-11-10Post Ipo Equity· $200M
2025-11-10Post Ipo Debt· $200M
2025-07-08Post Ipo Equity· $230M

Leadership Team

leader-logo
Andrew Robbins
CEO and President
linkedin
A
Abb Hayden
Senior Vice President of Sales
linkedin

Recent News

GlobeNewswire
Cogent Biosciences to Initiate New Drug Application (NDA) Submission for Bezuclastinib Under Real-Time Oncology Review (RTOR)
2026-01-20
GlobeNewswire
Cogent Biosciences Announces Anticipated 2026 Commercial and Clinical Milestones for Bezuclastinib and Precision Therapies Portfolio
2026-01-12
Investing.com
Cogent Biosciences stock falls after multiple insider sales
2025-12-31
Company data provided by crunchbase